Details of the Drug Reposition

General Information of This Drug (ID: DMDUGIQ)

Drug Name
Longeveron Mesenchymal Stem Cells   DMDUGIQ
Synonyms LMSC
Drug Type
Cell therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Hypoplastic left heart syndrome DISSLFZ4 LA89.3 Phase 1/2 [1]
Frailty DISPM6AE MG2A Phase 1/2 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03525418) Longeveron Mesenchymal Stem Cells (LMSCs) Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS) (ELPIS). U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT02982915) Human Mesenchymal Stem Cells (LMSCs) on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty (HERA). U.S. National Institutes of Health.